These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24478226)

  • 21. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials.
    Hoffmann R; Guagliumi G; Musumeci G; Reimers B; Petronio AS; Disco C; Amoroso G; Moses JW; Fitzgerald PJ; Schofer J; Leon MB; Breithardt G
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):499-506. PubMed ID: 16273564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravascular ultrasound analysis of small vessel lesions treated with the Sparrow coronary stent system: results of the CARE II trial.
    Kume T; Waseda K; Koo BK; Yock PG; Botelho R; Verheye S; Whitbourn R; Meredith I; Worthley S; Hai KT; Honda Y; Abizaid A; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):19-24. PubMed ID: 23413202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravascular ultrasound comparison of small coronary lesions between novel guidewire-based sirolimus-eluting stents and conventional sirolimus-eluting stents.
    Kume T; Waseda K; Koo BK; Botelho R; Verheye S; Whitbourn R; Meredith I; Worthley S; Hai KT; Yock PG; Azevedo de Oliveira FR; Abizaid A; Fitzgerald PJ; Honda Y
    J Invasive Cardiol; 2012 Oct; 24(10):489-93. PubMed ID: 23043031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of very late drug-eluting stent thrombosis using bare-metal stent evaluated using intravascular ultrasound and optical frequency domain imaging.
    Matsumoto K; Ehara S; Hasegawa T; Sakaguchi M; Yoshikawa J; Shimada K
    Cardiovasc Interv Ther; 2017 Apr; 32(2):159-164. PubMed ID: 26983634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravascular ultrasound insights from the Cobalt Chromium Stent With Antiproliferative for Restenosis II (COSTAR II) trial comparing CoStar and Taxus paclitaxel-eluting stents.
    Tsujino I; Koizumi T; Shimohama T; Ako J; Waseda K; Krucoff M; Honda Y; Fitzgerald PJ
    Cardiovasc Revasc Med; 2012; 13(2):111-8. PubMed ID: 22406056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
    Ribichini F; Romano M; Rosiello R; La Vecchia L; Cabianca E; Caramanno G; Milazzo D; Loschiavo P; Rigattieri S; Musarò S; Pironi B; Fiscella A; Amico F; Indolfi C; Spaccarotella C; Bartorelli A; Trabattoni D; Della Rovere F; Rolandi A; Beqaraj F; Belli R; Sangiorgio P; Villani R; Berni A; Sheiban I; Lopera Quijada MJ; Cappi B; Ribaldi L; Vassanelli C;
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1012-22. PubMed ID: 24055444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Healing responses after bifurcation stenting with the dedicated TRYTON Side-Branch Stent™ in combination with XIENCE-V™ stents: a clinical, angiography, fractional flow reserve, and optical coherence tomography study: the PYTON (Prospective evaluation of the TRYTON Side-Branch Stent™ with an additional XIENCE-v™ everolimus-eluting stent in coronary bifurcation lesions) study.
    Dubois C; Adriaenssens T; Ughi G; Wiyono S; Bennett J; Coosemans M; Ferdinande B; Sinnaeve P; D'hooge J; Desmet W
    Catheter Cardiovasc Interv; 2013 Feb; 81(3):E155-64. PubMed ID: 22745031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of zotarolimus-eluting stents with sirolimus-eluting and paclitaxel-eluting stents: intimal hyperplasia and vascular changes assessed by volumetric intravascular ultrasound analysis.
    Kang SJ; Mintz GS; Park DW; Lee SW; Kim YH; Lee CW; Han KH; Kim JJ; Park SW; Park SJ
    Circ Cardiovasc Interv; 2011 Apr; 4(2):139-45. PubMed ID: 21364151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2.
    Chevalier B; Silber S; Park SJ; Garcia E; Schuler G; Suryapranata H; Koolen J; Hauptmann KE; Wijns W; Morice MC; Carrie D; van Es GA; Nagai H; Detiege D; Paunovic D; Serruys PW;
    Circ Cardiovasc Interv; 2009 Jun; 2(3):188-95. PubMed ID: 20031715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
    Waseda K; Miyazawa A; Ako J; Hasegawa T; Tsujino I; Sakurai R; Yock PG; Honda Y; Kandzari DE; Leon MB; Fitzgerald PJ;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):779-84. PubMed ID: 19695548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis.
    Degertekin M; Serruys PW; Tanabe K; Lee CH; Sousa JE; Colombo A; Morice MC; Ligthart JM; de Feyter PJ
    Circulation; 2003 Dec; 108(22):2747-50. PubMed ID: 14638542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of lumen enlargement mechanisms achieved with the bifurcation dedicated BiOSS) stent versus classical coronary stent implantations by means of provisional side branch stenting strategy: an intravascular ultrasound study.
    Gil RJ; Bil J; Michałek A; Vassiliev D; Costa RA
    Int J Cardiovasc Imaging; 2013 Dec; 29(8):1667-76. PubMed ID: 23868287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III.
    Miyazawa A; Ako J; Hongo Y; Hur SH; Tsujino I; Courtney BK; Hassan AH; Kandzari DE; Honda Y; Fitzgerald PJ;
    Am Heart J; 2008 Jan; 155(1):108-13. PubMed ID: 18082499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sirolimus-eluting stent implantation in small coronary arteries: a three dimensional intravascular ultrasound study from the SIRIUS trial.
    Kaneda H; Ako J; Terashima M; Morino Y; Honda Y; Yock PG; Leon MB; Moses JW; Fitzgerald PJ;
    Int J Cardiol; 2010 Jan; 138(2):126-30. PubMed ID: 18804877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences of side branch jailing between left main-left anterior descending artery stenting and left main-left circumflex artery stenting with Nobori biolimus-eluting stent.
    Nakao F; Okamura T; Suetomi T; Yamada J; Nakamura T; Ueda T; Oda T; Kanemoto M; Ikeda Y; Fujii T; Yano M
    Heart Vessels; 2016 Dec; 31(12):1895-1903. PubMed ID: 26879743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective intravascular ultrasound investigation of the necessity for and efficacy of postdilation beyond nominal diameter of 3 current generation DES platforms for the percutaneous treatment of the left main coronary artery.
    Shand JA; Sharma D; Hanratty C; McClelland A; Menown IB; Spence MS; Richardson G; Herity NA; Walsh SJ
    Catheter Cardiovasc Interv; 2014 Sep; 84(3):351-8. PubMed ID: 24167078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late incomplete apposition after drug-eluting stent implantation: incidence and potential for adverse clinical outcomes.
    Siqueira DA; Abizaid AA; Costa Jde R; Feres F; Mattos LA; Staico R; Abizaid AA; Tanajura LF; Chaves A; Centemero M; Sousa AG; Sousa JE
    Eur Heart J; 2007 Jun; 28(11):1304-9. PubMed ID: 17478457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravascular Ultrasound Predictors of Major Adverse Cardiovascular Events After Implantation of Everolimus-eluting Stents for Long Coronary Lesions.
    Lee SY; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Rev Esp Cardiol (Engl Ed); 2017 Feb; 70(2):88-95. PubMed ID: 27789170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serial intravascular ultrasound observations from the Tryton first-in-man study.
    Maehara A; van Geuns RJ; Louvard Y; Müller R; Grube E; Morice MC; Davis HR; Kaplan AV; Onuma Y; Serruys PW; Mintz GS
    EuroIntervention; 2014 Aug; 10(4):475-83. PubMed ID: 25138185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.